Article
The putative effects of carboplatin based neoadjuvant chemotherapy on tumor microenvironment of epithelial ovarian carcinoma
2024-01-30
Abstract excerpt
For late-stage epithelial ovarian carcinoma (EOC) patients, carboplatin based neoadjuvant chemotherapy (NACT) followed interval debulking surgery (IDS) could be alternative choice. The failure of immune checkpoint inhibitors combining chemotherapy for EOC patients promote us to comprehensively understand the impact of NACT on the tumor mircroenvironment (TME) of EOC. <h4>Methods: </h4> The RNA-sequencing profiles...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 195835a8-91e8-5382-982b-f65f8fd26278
- DOI
- 10.21203/rs.3.rs-3900539/v1
